一步法筛查妊娠期糖尿病能否改善妊娠结局?
本研究为单中心回顾性队列研究,比较2015年7月从两步法改为一步法(IADPSG标准)筛查妊娠期糖尿病前后的妊娠结局。结果显示GDM诊断率从9.2%升至23.3%(P<.001),但初次剖宫产率、肩难产及出生体重≥4500g未见下降,子痫前期发生率降低。
要点
- 一步法使GDM诊断率增加3倍,但未改善初次剖宫产、肩难产等结局。
- 子痫前期发生率下降,但分析提示并非因GDM诊断增加所致。
- 出生体重≥4000g的大于胎龄儿发生率降低,但≥4500g无差异。
核心结论
- 采用IADPSG一步法后GDM诊断率增加3倍,但初次剖宫产、肩难产和出生体重≥4500g未见减少。
- 子痫前期发生率降低,但分析提示并非由GDM诊断增加所致。
- 在该人群中,GDM诊断率大幅增加未改善若干有临床意义的产科结局。
研究设计与样本
- 单中心回顾性队列研究,比较2015年7月从两步法改为一步法(IADPSG标准)前后的妊娠结局。
- 两步法组:预产期2012年1月1日至2015年10月1日,采用Carpenter和Coustan标准诊断GDM。
- 一步法组:经过6个月过渡期后,预产期2016年5月1日至2018年2月1日,采用IADPSG标准诊断GDM。
- 主要结局为初次剖宫产发生率,采用卡方检验、t检验和多因素logistic回归分析。
主要发现
- GDM诊断率从9.2%升至23.3%(P<.001)。
- 初次剖宫产率从19.4%升至22.2%(P=.001)。
- 肩难产发生率1.1% vs 0.8%(P=.07),无显著差异。
- 子痫前期发生率8.2% vs 10.9%(P<.001),一步法期间降低。
- 出生体重≥4500g发生率0.99% vs 0.86%(P=.5),无差异;≥4000g发生率8.0% vs 6.0%(P<.001),降低。
临床怎么用
- 一步法筛查虽大幅提高GDM诊断率,但未显著改善初次剖宫产、肩难产等结局,临床决策需权衡诊断增加带来的管理负担。
- 子痫前期发生率降低的机制需进一步研究,不应简单归因于GDM诊断增加。
局限性
- 单中心回顾性队列研究,结果外推需谨慎。
- 研究期间人群特征可能变化,虽经多因素校正但仍可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite considerate debate, the best method of diagnosing gestational diabetes mellitus remains unknown. A commonly used method of gestational diabetes mellitus screening in the United States is the 2-step method, which includes screening with a 50-gram, 1-hour glucose challenge followed by a 100-gram, 3-hour diagnostic oral glucose tolerance test. The International Association of Diabetes and Pregnancy Study Group has recommended the 1-step method using a 75-gram, 2-hour oral glucose tolerance test. The International Association of Diabetes and Pregnancy Study Group thresholds have been predicted to increase the rates of gestational diabetes mellitus, yet little is known about the effect on pregnancy outcomes, especially in the United States. OBJECTIVE: This study aimed to determine whether adoption of the 1-step method of gestational diabetes mellitus screening leads to improved obstetrical outcomes at a single academic institution. STUDY DESIGN: This is a retrospective cohort study of patients who delivered before and after a switch from the 2-step method to the 1-step International Association of Diabetes and Pregnancy Study Group method in July 2015. Women with a due date of January 1, 2012 through October 1, 2015 were diagnosed with gestational diabetes mellitus using the 2-step method with Carpenter and Coustan criteria. After a 6-month transition period, outcomes from women with a due date of May 1, 2016 through February 1, 2018, when the 1-step International Association of Diabetes and Pregnancy Study Group criteria were used to diagnose gestational diabetes mellitus, were evaluated. Women with gestational diabetes mellitus were managed similarly throughout the study period. The primary outcome was the incidence of primary cesarean delivery. Maternal and neonatal outcomes were compared using chi-square and t tests, and multivariable logistic regression was used to control for changes in the population. RESULTS: With the adoption of the International Association of Diabetes and Pregnancy Study Group method, the rates of gestational diabetes mellitus more than doubled, to 23.3% from 9.2% (P<.001). The rates of primary cesarean delivery increased with the International Association of Diabetes and Pregnancy Study Group criteria (22.2% vs 19.4%, P=.001), and the incidence of shoulder dystocia was not significantly different (1.1% vs 0.8%, P=.07). The rate of preeclampsia decreased during the time the 1-step method was in use (8.2% vs 10.9%, P<.001). The rate of macrosomia was not different using a definition of ≥4500 g (0.99% vs 0.86%, P=.5) but was reduced when using a definition of ≥4000 g (8.0% vs 6.0%, P<.001). The rate of neonatal intensive care unit admission did not change significantly. Controlling for maternal age, body mass index, race or ethnicity, chronic hypertension, and parity, the adjusted odds of a diagnosis of gestational diabetes mellitus increased 3-fold (adjusted odds ratio, 3.3; 95% confidence interval, 2.90-3.66) with 1-step testing, the adjusted odds of a shoulder dystocia increased (adjusted odds ratio, 1.48; 95% confidence interval, 0.97-2.25), and the adjusted odds of preeclampsia decreased (adjusted odds ratio, 0.64; 95% confidence interval, 0.55-0.74). There was no change in the adjusted odds of primary cesarean delivery (adjusted odds ratio, 1.05; 95% confidence interval, 0.94-1.17). CONCLUSION: Although the rates of gestational diabetes mellitus increased 3-fold with the adoption of the International Association of Diabetes and Pregnancy Study Group method, the rates of primary cesarean delivery, shoulder dystocia, and birthweight ≥4500 g did not decrease in our population. The incidence of preeclampsia decreased; our analysis suggests that this was not because of the increased diagnosis of gestational diabetes mellitus. In our patient population, a large increase in the rates of gestational diabetes mellitus did not lead to an improvement in several clinically meaningful obstetrical outcomes.
引用
- Ghaffari N, Gonzalez JM, Rosenstein MG, et al. Does the 1-step method of gestational diabetes mellitus screening improve pregnancy outcomes? Am J Obstet Gynecol MFM. 2020. PMID: 33345916. doi:10.1016/j.ajogmf.2020.100199
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。